Management Buyout vs Private Equity: Price, Control, and When You Actually Get Paid

A private equity firm almost always pays a higher headline price and puts more cash on the closing table. A management buyout almost always leaves you financing a large part of your own sale and waiting years to collect it. Control after closing runs the other way. The deciding number is not the multiple - it is how much of the price you hold in cash the day you sign.

What each one actually is

A management buyout is a sale to the people already running your company, funded by a bank loan against the company's assets, a modest slug of the team's personal savings, and a seller note you write yourself. The mechanics are in management buyout financing; the short version is that management rarely brings enough capital to buy you out, so the gap lands on you.

A private equity buyout is a sale to a fund whose business is buying control of companies, holding them for a defined period, and selling them again. How private equity actually finances a buyout walks through that capital stack line by line.

They are not mutually exclusive. CT Acquisitions' 2026 structural guide puts MBOs at roughly 14 percent of US lower-middle-market deal volume in 2025, while 41 percent of sub-$100 million transactions involved some form of management participation - meaning most "management buyouts" at this size are really sponsor deals with management riding along.

Price: what each buyer type pays

The gap is consistent and it is large. Management buyouts in the lower middle market clear at 4x to 6x trailing EBITDA for most industries - roughly 1x to 2x below a strategic acquirer. Private equity platform pricing over the same period, per GF Data's contributed deal set, ran 6.4x for $10-25 million enterprise values, 6.8x for $25-50 million, and 8.3x for $50-100 million in the first nine months of 2025.

There is no mystery about why. Management is negotiating against an owner they report to, with information nobody else in the process has, spending money they mostly do not have. A sponsor is competing against other sponsors, using a fund that is paid to deploy capital. Chambers and Partners states it plainly: "An MBO sale can deliver a lower headline price."

Before you weigh either offer, get your own range. How PE firms value a company explains the adjustments a buyer will make to your EBITDA, and the business valuation calculator will give you a defensible starting number.

The arithmetic on a $6 million EBITDA company

Take an invented company - $6,000,000 of adjusted EBITDA, no real-world counterpart - and price it both ways using the ranges above.

The management buyout. At 5.0x, enterprise value is $30,000,000. Senior lenders here underwrite 3.0x to 5.0x trailing EBITDA, averaging 3.8x; an MBO sits at the conservative end, so call it 3.0x, or $18,000,000. The team puts in $1,500,000 of personal capital. That leaves $10,500,000 - 35 percent of the price - as a seller note you hold at a 5 to 8 percent coupon over three to seven years. Seller financing shows up on 62 percent of surveyed lower-middle-market buyouts, with the owner taking 60 to 75 percent of enterprise value in cash at close.

The private equity deal. At 6.8x, enterprise value is $40,800,000. Senior debt at 3.8x is $22,800,000. The sponsor asks you to roll 20 percent of your proceeds - $8,160,000 - and funds the remaining $9,840,000 from the fund. You take $32,640,000 in cash at closing.

	Management buyout	Private equity buyout
Multiple	5.0x	6.8x
Enterprise value	$30,000,000	$40,800,000
Senior debt	$18,000,000	$22,800,000
Buyer equity	$1,500,000 (management savings)	$9,840,000 (fund)
Seller note you carry	$10,500,000	—
Equity you roll	—	$8,160,000
Cash to you at closing	$19,500,000	$32,640,000

A $10,800,000 gap in headline price becomes a $13,140,000 gap in cash at the closing table. That is the number owners almost never see until a term sheet is in front of them, because the conversation up to that point is conducted entirely in multiples.

What happens to the money you did not collect

Your $10,500,000 seller note is a loan to your own buyer, almost always subordinated to the $18,000,000 the bank lent. If the business stumbles after you hand over the keys, the bank gets paid and you wait. The coupon - say 7 percent, or $735,000 a year at the start - is interest income taxed at ordinary rates, not capital gains. The performance risk is real: CT Acquisitions reports that 22 percent of lower-middle-market MBOs closed between 2019 and 2021 traded for less than 1.0x invested equity at exit, versus 15 percent of comparable sponsor-led LBOs.

Your $8,160,000 of rollover equity is a different animal. It is not debt, it has no coupon, and it converts to cash only when the sponsor sells - the "second bite of the apple". That wait is lengthening. Bain & Company's 2026 outlook reports that "holding periods at exit are hovering around seven years, up from an average of five to six years from 2010 to 2021", against a backlog of "roughly 32,000 companies representing a stunning $3.8 trillion in value". Distributions as a share of net asset value sat at 14 percent, a level Bain notes has not been seen since 2008-09.

Neither instrument is bad. Both are illiquid, and neither belongs in the column you file under "what I got for the company".

Control after closing

This is where the MBO wins, and it is not close. The people running the company on Monday are the people who ran it on Friday. No new board, no investment committee, no consent list. The constraint is the bank's loan covenants, which are real but narrow.

A sponsor buys governance along with the equity. Even a minority position typically comes with board seats and a schedule of veto rights over budgets, hires, debt, and any sale. Chambers notes that private equity buyers "are typically looking for growth over a defined period (often 3 to 5 years)" and will want the founder or senior management to stay through it. What happens after private equity buys your company covers the first hundred days: the reporting cadence, the value-creation plan, and the CFO who now has two bosses.

The conflict nobody names in an MBO

There is a structural problem in a management buyout that no amount of goodwill fixes. The buyers are your fiduciaries. They know your customer concentration, your pending renewals, and which line of the forecast is soft - and every dollar they do not pay you is a dollar of their own return. That is arithmetic, not bad faith, and it is why public-company boards facing a management bid hand the negotiation to a special committee of independent directors with its own valuation and counsel.

Private companies rarely have independent directors to appoint, which makes your own representation the only check in the room. Goodwin's guidance to management teams makes the point from the other side, advising that "engaging separate legal representation can help ensure that the unique interests of management members are adequately protected". If your CFO has separate counsel and you do not, you are the only unrepresented party at your own sale; choosing an M&A advisory firm covers what to ask before you hire one.

Process risk compounds it. Retrading - the buyer lowering the price during or after diligence - hits roughly 30 to 40 percent of lower-middle-market buyouts, and a well-run MBO takes six to nine months. A team that cannot raise its piece at month seven leaves you with a stale process and a leadership group that knows exactly what you were willing to accept.

Side by side

Dimension	Management buyout	Private equity buyout
Typical LMM multiple	4x-6x EBITDA	6.4x-8.3x by size tier (GF Data, 9M 2025)
Cash at closing	60-75% of enterprise value	Higher, less rollover
What you carry afterward	Subordinated seller note, 3-7 years	Rollover equity, liquid only at the sponsor's exit
Governance after closing	Unchanged; bank covenants only	Board seats, consent rights, value-creation plan
Who funds it	Bank + management savings + you	Bank + committed fund capital
Certainty of funds	Depends on the team's borrowing capacity	Generally high once a sponsor is under LOI
Time to close	6-9 months	Comparable, with more process discipline
Your negotiating counterparty	Your own fiduciaries	An arm's-length professional buyer

Where the Independent Buyout sits

The comparison above has an obvious shape: the MBO gives you continuity and a smaller, slower check; the sponsor gives you a bigger, faster check and a new boss. An Independent Buyout is built to take the left column's governance and the right column's financing capacity.

The purchase is financed by borrowing against the company through a trust structure - sized off cash flow, the way a sponsor sizes a leveraged buyout, rather than off whatever the management team can pull from a home equity line. Existing leadership keeps running the business, with no financial sponsor on the board and no exit clock, and the proceeds do not depend on a large seller note to close the gap.

Depending on the facts, a qualifying sale can also defer capital gains under 26 U.S. Code § 1042, which lets a seller of qualified securities recognize gain "only to the extent that the amount realized on such sale exceeds the cost to the taxpayer of such qualified replacement property", provided the buying entity holds at least 30 percent of the stock immediately after the sale and the proceeds are reinvested within the statutory replacement period. A conventional MBO stock sale has no equivalent deferral. Confirm your own eligibility with a tax advisor - this is fact-specific, not a blanket promise.

If the buyers you have in mind are your children rather than your executives, the same funding question applies and family business succession planning takes it from there. If you have not yet narrowed the field to two options, business exit planning: every option lays out the full set.

Frequently asked questions

Does a management buyout always pay less than private equity? Not always, but the market data says usually. MBOs in the lower middle market cluster at 4x-6x EBITDA against sponsor platform pricing of 6.4x-8.3x depending on size. The gap widens further once you compare cash at closing rather than headline enterprise value.

Can I run both processes at the same time? Yes, and many owners do, but tell your management team before you start. Once the team knows a sponsor process is running they will price their own bid against it, and once a sponsor knows management wants to buy the company, it will factor that into retention terms.

Is rollover equity safer than a seller note? They fail differently. A seller note has a contractual coupon and maturity but sits behind the bank if things go wrong. Rollover equity has no maturity at all and pays only when the sponsor exits - around seven years, on current holding periods.

What if my management team cannot raise the money? That is the common outcome, and it is why most lower-middle-market "management buyouts" end up sponsor-financed with the team taking a minority stake. Ask for proof of financing before you grant exclusivity, not after.

Sources

• CT Acquisitions, "Selling Your Business to Management (MBO): 2026 Owner's Guide"
• CT Acquisitions, "What Is a Management Buyout (MBO)? 2026 Structural Guide"
• CapitalPad, "Lower Middle Market EBITDA Multiples: Data by Deal Size and Industry" (GF Data, first nine months of 2025)
• Bain & Company, "Private Equity Outlook 2026: Gaining Traction"
• Chambers and Partners, "Selling to private equity vs management buyout or trade buyer"
• Goodwin, "Thinking Outside the Buyout: Four Factors Management Teams Need to Get Right"
• 26 U.S. Code § 1042 - Cornell Law School Legal Information Institute

The bottom line

Compare the two on cash at closing, not on the multiple. On the invented company above, a 1.8-turn difference in multiple became a $13,140,000 difference in what hits your account the day you sign - and the balance sits either behind a bank as a subordinated note or inside a fund for seven years. Continuity is worth paying for, but you should know the price, and that is the conversation the industry consistently fails to have with owners.

If your company does $3M+ in EBITDA and you are weighing a management buyout against a sponsor process, talk to IBO Advisors about how an Independent Buyout prices against both.